EOS imaging system installed at Shriners Hospitals for Children in Philadelphia

Published on February 13, 2014 at 1:43 PM · No Comments

EOS imaging (Paris:EOSI) (NYSE Euronext, FR0011191766 - EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced the installation of the EOS imaging system at Shriners Hospitals for Children® in Philadelphia. This fourth installation within the Shriners Hospitals for Children system, a group of hospitals focused on caring for children with neuromusculoskeletal conditions and other specialty healthcare, validates the adoption of EOS technology as the standard of care for imaging within the network.

"The EOS System offers unparalleled benefits in terms of reduced radiation dose, quicker scanning procedures and diagnostic content, and we are pleased to help make this technology more accessible to Shriners' patients," said Amer Samdani, M.D., Chief of Surgery, Shriners Hospitals for Children-Philadelphia. "EOS' extremely low-dose system provides high quality 2D and 3D imaging that enables physicians to provide the care, attention and thoroughness necessary in the treatment of children with scoliosis or limb deformities. We are pleased to join the ranks of other Shriners Hospitals in Montreal, Portland, Ore. and Greenville, S.C, in utilizing this technology for our Philadelphia-area patients."

The Philadelphia Shriners Hospital treats more than 17,000 patients per year, with 68 percent of these patients treated for spinal conditions that require frequent imaging to track treatment progression. Scoliosis in particular requires regular screening over the course of many years of treatment, increasing exposure to harmful levels of radiation that may increase the likelihood of developing cancer in later years.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment